LORINI, SERENA
LORINI, SERENA
Medicina Sperimentale e Clinica
Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways.
2017 Gragnani, Laura; Tenori, Leonardo; Cerretelli, Guia; Meoni, Gaia; Lorini, Serena; Corti, Giampaolo; Giovannelli, Andrea; Monti, Monica; Caini, Patrizio; Bartoloni, Alessandro; Luchinat, Claudio; Zignego, ANNA LINDA
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2
2022 Visentini, Marcella; Gragnani, Laura; Santini, Stefano Angelo; Urraro, Teresa; Villa, Annalisa; Monti, Monica; Palladino, Andrea; Petraccia, Luisa; La Gualana, Francesca; Lorini, Serena; Marri, Silvia; Madia, Francesco; Stefanini, Lucia; Basili, Stefania; Fiorilli, Massimo; Ferri, Clodoveo; Zignego, Anna Linda; Casato, Milvia
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis
2021 Gragnani L.; Lorini S.; Marri S.; Basile U.; Santarlasci V.; Monti M.; Madia F.; Petraccia L.; Stasi C.; Marello N.; Napodano C.; Annunziato F.; Zignego A.L.
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis
2018 Gragnani, L.; Cerretelli, G.; Lorini, S.; Steidl, C.; Giovannelli, A.; Monti, M.; Petraccia, L.; Sadalla, S.; Urraro, T.; Caini, P.; Xheka, A.; Simone, A.; Arena, U.; Matucci-Cerinic, M.; Vergani, D.; Laffi, G.; Zignego, A.L.*
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases
2017 Gragnani, Laura; Fognani, Elisa; De Re, Valli; Libra, Massimo; Garozzo, Adriana; Caini, Patrizio; Cerretelli, Guia; Giovannelli, Andrea; Lorini, Serena; Monti, Monica; Bagnoli, Silvia; Piaceri, Irene; Zignego, Anna Linda
Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life
2021 Gragnani L.; Lorini S.; Marri S.; Vacchi C.; Madia F.; Monti M.; Ferri C.; Zignego A.L.
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia
2020 Basile U.; Marino M.; Gragnani L.; Napodano C.; Gulli F.; Pocino K.; Lorini S.; Santini S.A.; Basile V.; Miele L.; Zignego A.L.; Rapaccini G.L.
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression
2021 Pocino K.; Napodano C.; Gragnani L.; Ciasca G.; Colantuono S.; Marri S.; Vantaggio L.; Gulli F.; Lorini S.; Barini A.; Stefanile A.; Miele L.; Casato M.; Zignego A.L.; Rapaccini G.L.; Marino M.; Visentini M.; Basile U.
The metabolic fingerprints of HCV and HBV infections studied by Nuclear Magnetic Resonance Spectroscopy
2019 Meoni, Gaia; Lorini, Serena; Monti, Monica; Madia, Francesco; Corti, Giampaolo; Luchinat, Claudio; Zignego, Anna Linda; Tenori, Leonardo; Gragnani, Laura
The Relevance of MicroRNAs in the Pathogenesis and Prognosis of HCV-Disease: The Emergent Role of miR-17-92 in Cryoglobulinemic Vasculitis
2020 Lorini S.; Gragnani L.; Zignego A.L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways. | 2017 | Gragnani, Laura; Tenori, Leonardo; Cerretelli, Guia; Meoni, Gaia; Lorini, Serena; Corti, Giampaolo; Giovannelli, Andrea; Monti, Monica; Caini, Patrizio; Bartoloni, Alessandro; Luchinat, Claudio; Zignego, ANNA LINDA | |
| Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2 | 2022 | Visentini, Marcella; Gragnani, Laura; Santini, Stefano Angelo; Urraro, Teresa; Villa, Annalisa; Monti, Monica; Palladino, Andrea; Petraccia, Luisa; La Gualana, Francesca; Lorini, Serena; Marri, Silvia; Madia, Francesco; Stefanini, Lucia; Basili, Stefania; Fiorilli, Massimo; Ferri, Clodoveo; Zignego, Anna Linda; Casato, Milvia | |
| Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis | 2021 | Gragnani L.; Lorini S.; Marri S.; Basile U.; Santarlasci V.; Monti M.; Madia F.; Petraccia L.; Stasi C.; Marello N.; Napodano C.; Annunziato F.; Zignego A.L. | |
| Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis | 2018 | Gragnani, L.; Cerretelli, G.; Lorini, S.; Steidl, C.; Giovannelli, A.; Monti, M.; Petraccia, L.; Sadalla, S.; Urraro, T.; Caini, P.; Xheka, A.; Simone, A.; Arena, U.; Matucci-Cerinic, M.; Vergani, D.; Laffi, G.; Zignego, A.L.* | |
| Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases | 2017 | Gragnani, Laura; Fognani, Elisa; De Re, Valli; Libra, Massimo; Garozzo, Adriana; Caini, Patrizio; Cerretelli, Guia; Giovannelli, Andrea; Lorini, Serena; Monti, Monica; Bagnoli, Silvia; Piaceri, Irene; Zignego, Anna Linda | |
| Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life | 2021 | Gragnani L.; Lorini S.; Marri S.; Vacchi C.; Madia F.; Monti M.; Ferri C.; Zignego A.L. | |
| Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia | 2020 | Basile U.; Marino M.; Gragnani L.; Napodano C.; Gulli F.; Pocino K.; Lorini S.; Santini S.A.; Basile V.; Miele L.; Zignego A.L.; Rapaccini G.L. | |
| Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression | 2021 | Pocino K.; Napodano C.; Gragnani L.; Ciasca G.; Colantuono S.; Marri S.; Vantaggio L.; Gulli F.; Lorini S.; Barini A.; Stefanile A.; Miele L.; Casato M.; Zignego A.L.; Rapaccini G.L.; Marino M.; Visentini M.; Basile U. | |
| The metabolic fingerprints of HCV and HBV infections studied by Nuclear Magnetic Resonance Spectroscopy | 2019 | Meoni, Gaia; Lorini, Serena; Monti, Monica; Madia, Francesco; Corti, Giampaolo; Luchinat, Claudio; Zignego, Anna Linda; Tenori, Leonardo; Gragnani, Laura | |
| The Relevance of MicroRNAs in the Pathogenesis and Prognosis of HCV-Disease: The Emergent Role of miR-17-92 in Cryoglobulinemic Vasculitis | 2020 | Lorini S.; Gragnani L.; Zignego A.L. |